The global pediatric market essentially comprises of the healthcare services provided across various areas of healthcare industry. Children are often prone to illness and diseases and catch infections easily. Hence the pediatric market in terms of healthcare is a flourishing one, no matter what. Changes in lifestyle and unhealthy habits prevailing in the family largely contribute to the growth of this market.
The global pediatric market is valued to be $XX billion in 2015 and is poised to grow at a steady CAGR of X% to reach $XX billion by the end of forecast period. The steady growth can be attributed to the increasing complications and health issues in infants and children.
The global pediatric market is dominated by the Americas in 2015, which accounted for a market of x% of the global market revenue. They are followed by Europe, which is poised to grow at a CAGR of X%. Asia-Pacific is estimated to be the fastest growing region during the period under study owing to the rapid technological advances in medicine going on in the developing economies such as China and India.
The global market for pediatric interventional cardiology in 2014 is largely dominated by the Americas, especially in the U.S. due to the increasing instances of cardiac diseases among the children. APAC region is poised to exhibit highest growth rate during the forecast period due to the flooding investments in pediatrics by major healthcare players in this region, especially from China and India. The improved healthcare services and governmental healthcare reforms and increased awareness among people drive the market for pediatric interventional cardiology in the APAC region.
Profiled in this Report are:
- Claritas Genomics, Inc.
- Clarity Medical Systems, Inc.
- Covidien Public Limited Company
- Edwards Lifesciences
- Envision Radiology